Reichweite und Inhalt des neuen Auskunftsanspruchs der Krankenkassen nach § 129 Abs. 5c S. 4 SGB V
The article focuses on the question, how far the statutory health insurances’ right to information vis-à-vis pharmacies manufacturing cytostatic is reaching, in particular related to a potential right to information regarding the purchase prices of the pharmacies’ contract manufacturers…